| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |